Literature DB >> 8398600

Preparative and analytical separation of the zopiclone enantiomers and determination of their affinity to the benzodiazepine receptor binding site.

G Blaschke1, G Hempel, W E Müller.   

Abstract

We report the preparative separation of rac-zopiclone using malic acid as the resolving agent. Furthermore, two different methods for the analytical determination of zopiclone enantiomers by HPLC on chiral stationary phases are described. The benzodiazepine receptor binding of the isolated enantiomers was investigated. Half-maximal inhibitory concentrations of (+)- and (-)-zopiclone were 21 or 1,130 nmol/liter, respectively, indicating a more than 50 times higher affinity of the (+)-enantiomer toward the receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398600     DOI: 10.1002/chir.530050605

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  7 in total

Review 1.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

2.  The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone.

Authors:  Aleksi Tornio; Pertti J Neuvonen; Janne T Backman
Journal:  Eur J Clin Pharmacol       Date:  2006-07-11       Impact factor: 2.953

Review 3.  Eszopiclone: a review of its use in the treatment of insomnia.

Authors:  Philip I Hair; Paul L McCormack; Monique P Curran
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of zopiclone.

Authors:  C Fernandez; C Martin; F Gimenez; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

Review 5.  Chirality and drugs used in psychiatry: nice to know or need to know?

Authors:  R M Lane; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

6.  Spotlight on eszopiclone in insomnia.

Authors:  Philip I Hair; Paul L McCormack; Monique P Curran
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

7.  Comparison of the enantiomers of (+/-)-doxanthrine, a high efficacy full dopamine D(1) receptor agonist, and a reversal of enantioselectivity at D(1) versus alpha(2C) adrenergic receptors.

Authors:  Julie A Przybyla; Juan P Cueva; Benjamin R Chemel; K Joseph Hsu; David J Riese; John D McCorvy; Julia A Chester; David E Nichols; Val J Watts
Journal:  Eur Neuropsychopharmacol       Date:  2008-11-22       Impact factor: 4.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.